Forte Historical Balance Sheet

FBRX Stock

USD 21.71 1.92 9.70%

Trend analysis of Forte Biosciences balance sheet accounts such as Other Current Liabilities of 4 M or Total Current Liabilities of 6 M provides information on Forte Biosciences' total assets, liabilities, and equity, which is the actual value of Forte Biosciences to its prevalent stockholders. By breaking down trends over time using Forte Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Forte Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Forte Biosciences is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

About Forte Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Forte Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Forte Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Forte Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Forte currently owns. An asset can also be divided into two categories, current and non-current.

Forte Biosciences Balance Sheet Chart

At this time, Forte Biosciences' Accumulated Other Comprehensive Income is fairly stable compared to the past year. Common Stock is likely to rise to about 37.8 K in 2024, whereas Property Plant And Equipment Net is likely to drop slightly above 103.5 K in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Retained Earnings

Total Assets

Total assets refers to the total amount of Forte Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Forte Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Forte Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Forte Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most accounts from Forte Biosciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Forte Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.At this time, Forte Biosciences' Accumulated Other Comprehensive Income is fairly stable compared to the past year. Common Stock is likely to rise to about 37.8 K in 2024, whereas Property Plant And Equipment Net is likely to drop slightly above 103.5 K in 2024.

	2023	2024 (projected)
Short and Long Term Debt Total	7.9M	13.5M
Total Assets	39.0M	43.2M

Short Long Term Debt Total Total Assets

Forte Biosciences balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.52	0.55	0.64	0.83	0.7	-0.06	-0.74	0.57	0.33	0.69	-0.04	0.32	-0.38	1.0	0.92	-0.24	0.83	-0.38	0.45	-0.15	0.84	0.74	0.6	0.7	1.0
Short Long Term Debt Total	0.52		0.79	0.59	0.03	0.67	0.62	-0.56	0.56	-0.34	0.9	0.71	0.87	-0.32	0.49	0.32	0.31	0.68	-0.32	0.9	-0.63	0.56	0.7	0.91	0.67	0.49
Other Current Liab	0.55	0.79		0.93	0.13	0.77	0.35	-0.81	0.74	-0.09	0.84	0.38	0.62	-0.45	0.52	0.25	0.18	0.47	-0.45	0.58	-0.29	0.65	0.75	0.82	0.77	0.52
Total Current Liabilities	0.64	0.59	0.93		0.31	0.75	0.2	-0.84	0.75	0.04	0.7	0.09	0.4	-0.58	0.62	0.35	0.13	0.49	-0.58	0.41	-0.13	0.71	0.68	0.72	0.75	0.62
Total Stockholder Equity	0.83	0.03	0.13	0.31		0.35	-0.49	-0.53	0.24	0.6	0.25	-0.44	-0.15	-0.22	0.85	0.88	-0.62	0.54	-0.22	-0.08	0.17	0.62	0.46	0.06	0.35	0.85
Property Plant And Equipment Net	0.7	0.67	0.77	0.75	0.35		0.06	-0.77	0.97	0.23	0.88	0.13	0.32	-0.04	0.68	0.54	0.21	0.48	-0.04	0.62	0.09	0.53	0.76	0.77	1.0	0.68
Net Debt	-0.06	0.62	0.35	0.2	-0.49	0.06		-0.06	0.04	-0.93	0.29	0.66	0.77	-0.4	-0.09	-0.18	0.74	0.42	-0.4	0.67	-0.79	0.25	0.21	0.6	0.06	-0.08
Retained Earnings	-0.74	-0.56	-0.81	-0.84	-0.53	-0.77	-0.06		-0.73	-0.13	-0.7	0.11	-0.27	0.32	-0.72	-0.6	0.08	-0.53	0.32	-0.31	0.0	-0.73	-0.9	-0.57	-0.78	-0.73
Accounts Payable	0.57	0.56	0.74	0.75	0.24	0.97	0.04	-0.73		0.21	0.78	0.05	0.19	0.0	0.55	0.39	0.3	0.32	0.0	0.52	0.22	0.46	0.67	0.7	0.97	0.55
Cash	0.33	-0.34	-0.09	0.04	0.6	0.23	-0.93	-0.13	0.21		0.04	-0.49	-0.54	0.31	0.35	0.37	-0.7	-0.18	0.31	-0.38	0.68	-0.02	0.02	-0.28	0.23	0.35
Non Current Assets Total	0.69	0.9	0.84	0.7	0.25	0.88	0.29	-0.7	0.78	0.04		0.52	0.68	-0.14	0.66	0.48	0.15	0.62	-0.14	0.8	-0.31	0.65	0.79	0.89	0.88	0.67
Non Currrent Assets Other	-0.04	0.71	0.38	0.09	-0.44	0.13	0.66	0.11	0.05	-0.49	0.52		0.84	-0.13	-0.07	-0.25	0.35	0.26	-0.13	0.72	-0.74	0.15	0.08	0.58	0.13	-0.06
Other Assets	0.32	0.87	0.62	0.4	-0.15	0.32	0.77	-0.27	0.19	-0.54	0.68	0.84		-0.42	0.29	0.13	0.34	0.64	-0.42	0.84	-0.87	0.51	0.49	0.81	0.31	0.3
Long Term Debt	-0.38	-0.32	-0.45	-0.58	-0.22	-0.04	-0.4	0.32	0.0	0.31	-0.14	-0.13	-0.42		-0.38	-0.18	-0.04	-0.56	1.0	-0.19	0.58	-0.57	-0.15	-0.38	-0.04	-0.39
Cash And Short Term Investments	1.0	0.49	0.52	0.62	0.85	0.68	-0.09	-0.72	0.55	0.35	0.66	-0.07	0.29	-0.38		0.93	-0.26	0.82	-0.38	0.42	-0.13	0.83	0.73	0.57	0.68	1.0
Common Stock Total Equity	0.92	0.32	0.25	0.35	0.88	0.54	-0.18	-0.6	0.39	0.37	0.48	-0.25	0.13	-0.18	0.93		-0.3	0.78	-0.18	0.31	-0.03	0.67	0.68	0.37	0.54	0.93
Common Stock Shares Outstanding	-0.24	0.31	0.18	0.13	-0.62	0.21	0.74	0.08	0.3	-0.7	0.15	0.35	0.34	-0.04	-0.26	-0.3		0.08	-0.04	0.54	-0.24	-0.07	0.02	0.48	0.21	-0.25
Short Term Investments	0.83	0.68	0.47	0.49	0.54	0.48	0.42	-0.53	0.32	-0.18	0.62	0.26	0.64	-0.56	0.82	0.78	0.08		-0.56	0.69	-0.61	0.79	0.66	0.72	0.48	0.83
Long Term Debt Total	-0.38	-0.32	-0.45	-0.58	-0.22	-0.04	-0.4	0.32	0.0	0.31	-0.14	-0.13	-0.42	1.0	-0.38	-0.18	-0.04	-0.56		-0.19	0.58	-0.57	-0.15	-0.38	-0.04	-0.39
Non Current Liabilities Total	0.45	0.9	0.58	0.41	-0.08	0.62	0.67	-0.31	0.52	-0.38	0.8	0.72	0.84	-0.19	0.42	0.31	0.54	0.69	-0.19		-0.61	0.44	0.54	0.93	0.62	0.42
Capital Surpluse	-0.15	-0.63	-0.29	-0.13	0.17	0.09	-0.79	0.0	0.22	0.68	-0.31	-0.74	-0.87	0.58	-0.13	-0.03	-0.24	-0.61	0.58	-0.61		-0.38	-0.18	-0.51	0.09	-0.13
Other Current Assets	0.84	0.56	0.65	0.71	0.62	0.53	0.25	-0.73	0.46	-0.02	0.65	0.15	0.51	-0.57	0.83	0.67	-0.07	0.79	-0.57	0.44	-0.38		0.72	0.63	0.53	0.84
Other Stockholder Equity	0.74	0.7	0.75	0.68	0.46	0.76	0.21	-0.9	0.67	0.02	0.79	0.08	0.49	-0.15	0.73	0.68	0.02	0.66	-0.15	0.54	-0.18	0.72		0.69	0.76	0.73
Total Liab	0.6	0.91	0.82	0.72	0.06	0.77	0.6	-0.57	0.7	-0.28	0.89	0.58	0.81	-0.38	0.57	0.37	0.48	0.72	-0.38	0.93	-0.51	0.63	0.69		0.77	0.57
Property Plant And Equipment Gross	0.7	0.67	0.77	0.75	0.35	1.0	0.06	-0.78	0.97	0.23	0.88	0.13	0.31	-0.04	0.68	0.54	0.21	0.48	-0.04	0.62	0.09	0.53	0.76	0.77		0.68
Total Current Assets	1.0	0.49	0.52	0.62	0.85	0.68	-0.08	-0.73	0.55	0.35	0.67	-0.06	0.3	-0.39	1.0	0.93	-0.25	0.83	-0.39	0.42	-0.13	0.84	0.73	0.57	0.68

Click cells to compare fundamentals

Forte Biosciences Account Relationship Matchups

Forte Biosciences balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.7M	61.2M	43.3M	42.0M	39.0M	43.2M
Other Current Liab	343.2K	1.0M	812K	2.0M	2.2M	4.0M
Total Current Liabilities	1.9M	2.3M	1.8M	3.2M	3.7M	6.0M
Total Stockholder Equity	(4.8M)	59.0M	41.5M	38.8M	35.3M	42.2M
Property Plant And Equipment Net	4.0M	150.6K	97K	0.0	109K	103.6K
Net Debt	1.8M	(58.8M)	(42.0M)	(41.1M)	(12.0M)	(12.6M)
Retained Earnings	(5.0M)	(51.5M)	(73.2M)	(87.0M)	(118.5M)	(124.4M)
Accounts Payable	1.6M	1.2M	946K	1.2M	1.4M	1.3M
Cash	6.9M	58.8M	42.0M	41.1M	12.0M	11.4M
Non Current Assets Total	150.6K	1.3M	786K	486K	653K	620.4K
Other Assets	227K	1.4M	0.0	1.0	0.9	0.86
Cash And Short Term Investments	6.9M	58.8M	42.0M	41.1M	37.1M	41.0M
Common Stock Total Equity	20K	23K	1K	13K	11.7K	9.9K
Common Stock Shares Outstanding	2.1M	294.4K	558.7K	695.3K	1.3M	862.0K
Short Term Investments	52.8M	55.3M	12.8M	25.2M	22.6M	29.7M
Liabilities And Stockholders Equity	7.7M	61.2M	43.3M	42.0M	39.0M	43.2M
Non Current Liabilities Total	28.4M	10.5M	1.2M	946K	1.2M	0.0
Other Current Assets	53.2K	1.1M	476K	411K	1.2M	831.3K
Other Stockholder Equity	(10.3M)	49.2M	71.4M	125.8M	153.8M	96.1M
Total Liab	12.4M	2.3M	1.8M	3.2M	3.7M	3.5M
Property Plant And Equipment Gross	4.0M	150.6K	97K	0.0	118K	112.1K
Total Current Assets	7.5M	59.9M	42.5M	41.5M	38.3M	41.8M
Accumulated Other Comprehensive Income	10K	(61.2M)	(43.3M)	4K	3.6K	3.8K
Common Stock	23K	1K	13K	21K	36K	37.8K
Property Plant Equipment	1.2M	4.0M	152K	97K	87.3K	82.9K
Net Tangible Assets	(4.8M)	59.0M	41.5M	38.8M	44.6M	29.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Forte Historical Balance Sheet

About Forte Balance Sheet Analysis

Forte Biosciences Balance Sheet Chart

Total Assets

Total Current Liabilities

Retained Earnings

Forte Biosciences balance sheet Correlations

Forte Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Forte Biosciences balance sheet Accounts

Also Currently Popular

Additional Tools for Forte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Long Term Debt Total	+ 1.0	Long Term Debt
Total Current Assets	+ 1.0	Cash And Short Term Investments
Accounts Payable	+ 0.97	Property Plant And Equipment Net

Cash	- 0.93	Net Debt
Other Stockholder Equity	- 0.9	Retained Earnings
Capital Surpluse	- 0.87	Other Assets
Retained Earnings	- 0.84	Total Current Liabilities
Retained Earnings	- 0.81	Other Current Liab
Capital Surpluse	- 0.79	Net Debt